Pharmacist-led educational interventions, including patient education and medication review, may improve the discontinuation of benzodiazepines and similar sedative-hypnotic drugs, according to an April 2 study published in BMJ.
The study matters because benzodiazepines are commonly prescribed for anxiety and sleep disorders but can cause dependence and other health risks if used long-term. Finding effective ways to help patients stop using these medications is important for public health.
Researchers conducted a systematic review and meta-analysis of 49 randomized controlled trials involving more than 39,000 patients. Most participants were around 50 years old. The analysis found that pharmacist-led educational approaches showed promise in helping people discontinue these drugs.
The review also looked at other interventions such as tapering schedules, physician education, cognitive behavioral therapy, mindfulness practices, or drug-assisted tapering. It found limited evidence that these methods helped patients stop taking benzodiazepines or related medications.
However, the researchers said that the available evidence may be biased and imprecise. They noted that most results applied mainly to individuals in their 50s without significant mental health conditions.
As research continues on this topic, future studies could focus on broader age groups and those with mental health challenges to better understand which strategies work best for different populations.
Alerts Sign-up